Target Audience

This program is designed for pediatricians, pediatric nurses and nurse practitioners.

Learning Objectives: General Sessions

Upon completion of this activity, attendees should be better able to:

  • Identify cutaneous eruptions that are markers of common and less common systemic illnesses
  • Summarize key vaccinations in pediatric practice, as well as mechanisms in place to assess their safety
  • Recognize vaccine-preventable diseases during community outbreaks
  • Assess the microbiome and its contribution to infant health and childhood development
  • Assess best practices for children returning to school following an infection
  • Summarize management and treatment options for fever and recurrent fever syndromes in infants and children
  • Evaluate new information regarding the assessment and treatment of syphilis and staphylococcus aureus infections
  • Outline the updated understanding and treatment of Kawasaki disease
  • Review evidence-based literature about pediatric infectious diseases published over the past year
  • Evaluate emerging infections and comprehensive management practices
  • Examine current challenges of, and management practices for vector-borne infectious diseases
  • Summarize current treatment of mononucleosis
  • Explore issues that present in the outpatient setting, including the interpretation of test results, accessing guidelines, and the use of social media
  • Outline diagnostic approaches for suspected infectious diseases
  • Examine infectious disease risks in patients who are receiving biologic response modifiers
  • Review cases for which pediatric infectious disease guidance has been sought over the phone

Learning Objectives: Saturday Breakfast Seminar

  • Utilize appropriate diagnosis and assessment tools for the diagnosis of patients with AD and refer to a specialist as warranted
  • Apply new steroid-sparing options to treat patients with mild-to-moderate AD
  • Assess the latest evidence regarding emerging oral options to manage patients with AD who have not benefited from topical options alone

Learning Objectives: Saturday Lunch Seminar

  • Utilize diagnostic assays for pediatric and adolescent influenza that have demonstrated sensitivity, specificity, and convenience
  • Apply the mechanisms of action, efficacy, and safety of conventional and new antiviral agents to improve the treatment of pediatric and adolescent influenza

Learning Objectives: Sunday Lunch Seminar

  • Summarize the risks associated with molluscum contagiosum and its impact on patients, particularly children with immunodeficiencies
  • Evaluate conventional and emerging therapies for molluscum contagiosum that may reduce the adverse impact on patients, as well as transmission of the virus to others
This continuing education activity is provided by

IDC New York 2019 is supported, in part, by educational grants from Genentech, Inc.; Merck & Co., Inc.; Pfizer, Inc.; and Verrica Pharmaceuticals Inc.

Accreditation: Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation: Vindico Medical Education designates this live activity for a maximum of 17 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Accreditation: Vindico Medical Education, LLC is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Credit Designation: Vindico will provide 14 contact hours for nurses.

Nurse practitioners can apply for AMA PRA Category 1 Credit(s)™ through the American Academy of Nurse Practitioners Certification Board (AANPCB). AANPCB will accept AMA PRA Category 1 Credit(s)™ from organizations accredited by Accreditation Council for Continuing Medical Education.

Faculty/Planner Disclosure Policy: In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all planners, teachers and authors involved in the development of CME content are required to disclose to the accredited provider their relevant financial relationships. Relevant financial relationships will be disclosed to the activity audience.

Notice: Faculty, topics, program schedule and credit hours are subject to change. Audiotaping or videotaping is prohibited without written permission from the program director and the Office of Medical Affairs and Compliance.